ABSTRACT
BACKGROUND AND OBJECTIVES: Radiofrequency ablation has recently been used for the treatment of benign thyroid nodules, with outstanding results. However, in most studies, the procedure was usually performed by a radiologist or surgeon. This study aimed to evaluate the efficacy and safety of radiofrequency ablation for nodules >2 cm performed by an endocrinologist with several years of experience performing fine-needle aspiration cytology. MATERIALS AND METHODS: This study was a cross-sectional analysis of 111 patients who received radiofrequency ablation between April 2010 and July 2013. A total of 73 patients with 75 nodules >2 cm in diameter with at least 6 months of follow-up examinations were included. RESULTS: The mean follow-up period was 11.5 months. The mean nodule volume decreased from 17.0+/-15.3 mL preoperatively to 6.0+/-8.5 mL postoperatively, with a mean volume reduction of 69.7%. There were no major complications, and only 1 patient (1.3%) presented with a minor complication (hemorrhaging of the thyroid parenchyma). CONCLUSION: Radiofrequency ablation is a safe method for reducing benign thyroid nodules, and is not associated with any major complications.
Subject(s)
Humans , Biopsy, Fine-Needle , Catheter Ablation , Cross-Sectional Studies , Follow-Up Studies , Thyroid Gland , Thyroid NoduleABSTRACT
Amyloidosis is defined as the presence of extra-cellular deposits of an insoluble fibrillar protein, amyloid. The pulmonary involvement of amyloidosis is usually classified as tracheobronchial, parenchymal nodular, or diffuse alveolar septal. A single nodular lesion can mimic various conditions, including malignancy, pulmonary tuberculosis, and fungal infection. To date, only one case of nodular pulmonary amyloidosis has been reported in Korea, a case involving multiple nodular lesions. Here, we report and discuss the case of a patient having single nodular amyloidosis.